Page 97 - TD-4-3

Tumor Discovery Sorafenib induces MVPs in NSCLC

10. Sahu RP, Konger RL, Travers JB. Platelet-activating peroxide. J Biol Chem. 1992;267(21):15168-15175.
factor-receptor and tumor immunity. JSM Cell Dev Biol. doi: 10.1016/S0021-9258(18)42161-8
2014;2(1):1008.
21. Smiley PL, Patel KD, Stremler KE, Zimmerman GA,
doi: 10.47739/2379-061X/1008
Prescott SM, McIntyre TM. Novel neutrophil agonists:
11. Sahu RP, Harrison KA, Weyerbacher J, et al. Radiation Oxidatively-fragmented phosphatidylcholines. In:
therapy generates platelet-activating factor agonists. Bailey JM, editor. Prostaglandins, Leukotrienes, Lipoxins, and
Oncotarget. 2016;7(15):20788-20800. PAF: Mechanism of Action, Molecular Biology, and Clinical
doi: 10.18632/oncotarget.7878 Applications. Boston, MA: Springer US; 1991. p. 269-279.
12. Sahu RP, Turner MJ, DaSilva SC, et al. The environmental 22. Fahy K, Liu L, Rapp CM, et al. UVB-generated microvesicle
stressor ultraviolet B radiation inhibits murine antitumor particles: A novel pathway by which a skin-specific
immunity through its ability to generate platelet-activating stimulus could exert systemic effects. Photochem Photobiol.
factor agonists. Carcinogenesis. 2012;33(7):1360-1367. 2017;93(4):937-942.
doi: 10.1093/carcin/bgs152 doi: 10.1111/php.12703
13. Sahu RP, Ocana JA, Harrison KA, et al. Chemotherapeutic 23. Maacha S, Bhat AA, Jimenez L, et al. Extracellular vesicles-
agents subvert tumor immunity by generating agonists of mediated intercellular communication: Roles in the tumor
platelet-activating factor. Cancer Res. 2014;74(23):7069-7078. microenvironment and anti-cancer drug resistance. Mol
Cancer. 2019;18(1):55.
doi: 10.1158/0008-5472.Can-14-2043
doi: 10.1186/s12943-019-0965-7
14. Chauhan SJ, Thyagarajan A, Chen Y, Travers JB, Sahu RP.
Platelet-activating factor-receptor signaling mediates 24. Muralidharan-Chari V, Kohan HG, Asimakopoulos AG,
targeted therapies-induced microvesicle particles release in et al. Microvesicle removal of anticancer drugs contributes
lung cancer cells. Int J Mol Sci. 2020;21(22):8517. to drug resistance in human pancreatic cancer cells.
Oncotarget. 2016;7(31):50365-50379.
doi: 10.3390/ijms21228517
doi: 10.18632/oncotarget.10395
15. Chauhan SJ, Thyagarajan A, Sahu RP. Effects of miRNA-
149-5p and platelet-activating factor-receptor signaling on 25. Yang Q, Xu J, Gu J, et al. Extracellular vesicles in cancer drug
the growth and targeted therapy response on lung cancer resistance: Roles, mechanisms, and implications. Adv Sci.
cells. Int J Mol Sci. 2022;23(12):6772. 2022;9(34):2201609.
doi: 10.3390/ijms23126772 doi: 10.1002/advs.202201609
16. Travers JB, Rohan JG, Sahu RP. New insights into the 26. Yang Y, Li S, Wang Y, Zhao Y, Li Q. Protein tyrosine kinase
pathologic roles of the platelet-activating factor system. inhibitor resistance in malignant tumors: Molecular
Front Endocrinol (Lausanne). 2021;12:624132. mechanisms and future perspective. Signal Transduct Target
Ther. 2022;7(1):329.
doi: 10.3389/fendo.2021.624132
doi: 10.1038/s41392-022-01168-8
17. Bihl JC, Rapp CM, Chen Y, Travers JB. UVB generates
microvesicle particle release in part due to platelet-activating 27. Catalano M, O’Driscoll L. Inhibiting extracellular vesicles
factor signaling. Photochem Photobiol. 2016;92(3):503-506. formation and release: A review of EV inhibitors. J Extracell
Vesicles. 2020;9(1):1703244.
doi: 10.1111/php.12577
doi: 10.1080/20013078.2019.1703244
18. Liu L, Awoyemi AA, Fahy KE, et al. Keratinocyte-derived
microvesicle particles mediate ultraviolet B radiation- 28. Bianco F, Perrotta C, Novellino L, et al. Acid sphingomyelinase
induced systemic immunosuppression. J Clin Invest. activity triggers microparticle release from glial cells. EMBO
2021;131(10):e144963. J. 2009;28(8):1043-1054.
doi: 10.1172/jci144963 doi: 10.1038/emboj.2009.45
19. Thyagarajan A, Kadam SM, Liu L, et al. Gemcitabine 29. Deng L, Peng Y, Jiang Y, et al. Imipramine protects against
induces microvesicle particle release in a platelet-activating bone loss by inhibition of osteoblast-derived microvesicles.
factor-receptor-dependent manner via modulation of the Int J Mol Sci. 2017;18(5):1013.
MAPK pathway in pancreatic cancer cells. Int J Mol Sci. doi: 10.3390/ijms18051013
2018;20(1):32.
30. Kosgodage US, Trindade RP, Thompson PR, Inal JM,
doi: 10.3390/ijms20010032 Lange S. Chloramidine/bisindolylmaleimide-i-mediated
20. Patel KD, Zimmerman GA, Prescott SM, McIntyre TM. Novel inhibition of exosome and microvesicle release and
leukocyte agonists are released by endothelial cells exposed to enhanced efficacy of cancer chemotherapy. Int J Mol Sci.

Volume 4 Issue 3 (2025) 89 doi: 10.36922/TD025110019